Results 231 to 240 of about 1,273,913 (331)

Circulating Bacterial DNA as a Novel Blood-Based Biomarker in Type 2 Diabetes Mellitus (DM2): Results from the PROMOTERA Study. [PDF]

open access: yesInt J Mol Sci
Giacconi R   +19 more
europepmc   +1 more source

Circulating Bacterial DNA as Plasma Biomarkers for Lung Cancer Early Detection. [PDF]

open access: yesMicroorganisms, 2023
Zhou H   +5 more
europepmc   +1 more source

Effects of Bacterial DNA on Cytokine Production by (NZB/NZW)F1 Mice [PDF]

open access: bronze, 1998
Gary S. Gilkeson   +5 more
openalex   +1 more source

Shedding Light on the Cellular Uptake Mechanisms of Bioactive Glass Nanoparticles as Controlled Intracellular Delivery Platforms: A Review of the Recent Literature

open access: yesAdvanced Healthcare Materials, EarlyView.
This review summarizes the main uptake pathways of bioactive glass nanoparticles (BGNs) and their intracellular localization, highlighting that BGNs are mainly internalized and entrapped within endosomes/lysosomes. Strategies for controlled intracellular ion release, with implications for targeted modulation of cell behavior, are discussed. The need to
Andrada‐Ioana Damian‐Buda   +1 more
wiley   +1 more source

Expanding the diversity of bacterial DNA partitioning: A CTP-independent ParAB<i>S</i> system for plasmid partitioning in <i>Streptomyces</i>. [PDF]

open access: yesProc Natl Acad Sci U S A
Sukhoverkov KV   +8 more
europepmc   +1 more source

Metronidazole‐Loaded Cyclodextrin Nanogels for Antibacterial Therapy and Microbiota Regulation in Periodontitis

open access: yesAdvanced Healthcare Materials, EarlyView.
A methacrylamide β‐cyclodextrin‐based nanogel (MACD nGel) is developed to load the antimicrobial drug Metronidazole (MNZ) for topical delivery for the treatment of periodontitis. It is demonstrated that cyclodextrin nanogel (nGel) loaded with metronidazole provides an efficient drug delivery route but also has potential clinical applications and offers
Yanjing Ji   +8 more
wiley   +1 more source

Body Biofluids for Minimally‐Invasive Diagnostics: Insights, Challenges, Emerging Technologies, and Clinical Potential

open access: yesAdvanced Healthcare Materials, EarlyView.
Recent advances in diagnostics have accelerated the development of miniaturized wearable technologies for the continuous monitoring of diseases. This paradigm is shifting healthcare away from invasive, centralized blood tests toward decentralized monitoring, using alternative body biofluids.
Lanka Tata Rao   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy